Corcept Therapeutics's total assets for Q3 2025 were $823.61M, an increase of 2.73% from the previous quarter. CORT total liabilities were $191.71M for the fiscal quarter, a 15.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.